These findings suggest that sumoylation, especially at K33, acts as a key regulatory switch that enhances cyclin D1’s oncogenic activity by promoting its nuclear accumulation, further emphasizing the importance of PTMs in cancer progression. This evidence concerns the gene CCND1 and cancer.